Five-Year Antibody Persistence Following a Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) Booster in JE-CV-Primed Children in the Philippines.
Autor: | Capeding MR; Research Institute for Tropical Medicine, Muntinlupa City, Philippines., Alberto ER; Research Institute for Tropical Medicine, Muntinlupa City, Philippines., Bouckenooghe A; Clinical Sciences and Medical Affairs, Sanofi Pasteur, Singapore., Laot TM; Clinical Sciences, Sanofi Pasteur, Taguig City, Philippines., Chansinghakul D; Clinical Sciences, Sanofi Pasteur, Bangkok, Thailand., Monfredo C; Clinical Programs, Sanofi Pasteur, Marcy l'Etoile., Machabert T; Soladis, Lyon., Feroldi E; Global Clinical Sciences, Sanofi Pasteur, Marcy l'Etoile, France. |
---|---|
Jazyk: | angličtina |
Zdroj: | The Journal of infectious diseases [J Infect Dis] 2018 Jan 30; Vol. 217 (4), pp. 567-571. |
DOI: | 10.1093/infdis/jix601 |
Abstrakt: | Clinical Trials Registration: NCT01190228. (© The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America.) |
Databáze: | MEDLINE |
Externí odkaz: |